Clinical Trial Update: Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating thrombolysis combined with edaravone dexborneol for reducing hemorrhagic transformation in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Ischemic

Drugs mentioned

• Edaravone Dexborneol
• Thrombolysis

Snippet

Sponsor: Huashan Hospital | Conditions: Stroke, Ischemic | Phase 2 | Status: UNKNOWN